Depression and Anxiety Trial, Recruiting NCT07679204 Sponsor: Elazığ Mental Health and Diseases Hospital Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07679204
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 – People diagnosed with Bipolar Disorder Type II (BD-II):

  • A formal diagnosis of Bipolar Disorder Type II, confirmed using standard diagnostic guidelines (DSM-5-TR)
  • Currently in a remission period (symptoms are not active at the time of joining)
  • Aged 18 years or older
  • Has given written informed consent to participate

Group 2 – People diagnosed with Major Depressive Disorder (MDD):

  • A formal diagnosis of Major Depressive Disorder, confirmed using standard diagnostic guidelines (DSM-5-TR)
  • Currently in a remission period (symptoms are not active at the time of joining)
  • Aged 18 years or older
  • Has given written informed consent to participate

Group 3 – Healthy Control participants:

  • No diagnosis of any psychiatric condition
  • No immune system or whole-body (systemic) illness
  • Has not taken any medications for at least one month before joining
  • Aged 18 years or older
  • Has given written informed consent to participate

Group 4 – Healthy biological father and/or mother of someone with Bipolar Disorder Type II (BD-II):

  • No diagnosis of any psychiatric condition
  • No immune system or whole-body (systemic) illness
  • Has not taken any medications for at least one month before joining
  • Aged 18 years or older
  • Has given written informed consent to participate

Group 5 – Healthy biological father and/or mother of someone with Major Depressive Disorder (MDD):

  • No diagnosis of any psychiatric condition
  • No immune system or whole-body (systemic) illness
  • Has not taken any medications for at least one month before joining
  • Aged 18 years or older
  • Has given written informed consent to participate

Group 6 – Healthy biological father and/or mother of a Healthy Control participant:

  • No diagnosis of any psychiatric condition
  • No immune system or whole-body (systemic) illness
  • Has not taken any medications for at least one month before joining
  • Aged 18 years or older
  • Has given written informed consent to participate

Who may not be able to join:

The following criteria apply across all six groups listed above:

  • High blood pressure (hypertension)
  • Diabetes
  • Chronic kidney disease
  • Rheumatoid arthritis (an autoimmune joint condition)
  • Systemic lupus erythematosus (an autoimmune disease affecting multiple parts of the body)
  • Any heart condition
  • Severe neurological disorders (serious conditions affecting the brain or nervous system)
  • Any immune system or whole-body (systemic) illness
  • Current use of alcohol, drugs, or other substances
  • For the BD-II and MDD groups: having a primary psychiatric diagnosis other than the one being studied, or not currently being in remission
  • For the healthy control and parent groups: having any psychiatric diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mehmet Hamdi Örüm, Associate Professor, MD, Elazığ Mental Health and Diseases Hospital

Phone: +905382207558

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Elazığ Mental Health and Diseases Hospital
Registry
ClinicalTrials.gov
Start date
23 December 2024
Est. completion
24 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Type D Personality Scale (DS14)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov